Understanding Lesbian, Bisexual and Queer Women’s Experiences of Alcohol, Substance use and Health: The UnLEASH online cohort study
UnLEASH is an online cohort study of substance use among lesbian, bisexual and queer women in Australia.
UnLEASH is an online cohort study of substance use among lesbian, bisexual and queer women in Australia.
ADAPT stands for Australians’ Drug Use: Adapting to Pandemic Threats. The ADAPT study is exploring the short and long-term impact of the COVID-19 pandemic on the experiences of Australians who use illicit drugs.
The Safe Space and Take Kare Ambassador program was established in response to concerns about the safety of young people at night, specifically to get kids home safely.
The objectives of the program are to:
This project will provide an international literature review of the approaches taken in Ireland and other jurisdictions to simple possession drug offences.
This is a PhD project of Vivienne Moxham-Hall (supervised by Professor Alison Ritter and Dr Caitlin Hughes) investigating the utility of indexes as a measure of drug policy.
We have developed a multidisciplinary global consortium of researchers who can provide independent high-quality evidence regarding the scale of illicit drug use, harms, access to services at country, regional and global levels, and build capacity for better data in these areas.
NDARC has been invited to undertake research in partnership with NSW Aboriginal drug and alcohol Residential Rehabilitation Services. This research is unique in being embedded into the routine delivery of their services.
Cannabis remains one of the most commonly used psychoactive substances in the United States, and current epidemiological studies indicate broadening acceptability. This aim of this project is to decrease the burden of psychoactive substance use in the US.
Substance use among pregnant women is a significant public health issue. A range of adverse effects have been noted including increased risk of miscarriage and still birth, reduction in fetal growth, birth defects, developmental delay, growth retardation and neurological abnormalities.
This project will review the evidence for the medicinal use of cannabis and cannabinoid products for a number of key medical conditions.